Lineage-specific transcriptional regulation of DICER by MITF in melanocytes

Cell

Volumn 141, Issue 6, 2010, Pages 994-1005

  Levy, Carmit ^a   Khaled, Mehdi ^a   Robinson, Kathleen C ^a   Veguilla, Rosa A ^a   Chen, Po Hao ^a   Yokoyama, Satoru ^a   Makino, Eiichi ^a   Lu, Jun ^a,b,c   Larue, Lionel ^d   Beermann, Friedrich ^e   Chin, Lynda ^c   Bosenberg, Marcus ^f   Song, Jun S ^g   Fisher, David E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d INSTITUT CURIE   (France)

^e SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Cellbio; Devbio; RNA

Indexed keywords

ALPHA INTERMEDIN; BIM PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DICER; FORSKOLIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; MELANOCYTE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 77953694905     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.05.004     Document Type: Article

References (81)

1. Ambros V., Lee R.C., Lavanway A., Williams P.T., Jewell D. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol. 2003, 13:807-818.
2. Asada S., Takahashi T., Isodono K., Adachi A., Imoto H., Ogata T., Ueyama T., Matsubara H., Oh H. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am. J. Physiol. 2008, 295:H2512-H2521.
3. Barbato C., Ciotti M.T., Serafino A., Calissano P., Cogoni C. Dicer expression and localization in post-mitotic neurons. Brain Res. 2007, 1175:17-27.
4. Berezikov E., Chung W.J., Willis J., Cuppen E., Lai E.C. Mammalian mirtron genes. Mol. Cell 2007, 28:328-336.
5. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409:363-366.
6. Bertolotto C., Abbe P., Hemesath T.J., Bille K., Fisher D.E., Ortonne J.P., Ballotti R. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 1998, 142:827-835.
7. Bosenberg M., Muthusamy V., Curley D.P., Wang Z., Hobbs C., Nelson B., Nogueira C., Horner J.W., Depinho R., Chin L. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 2006, 44:262-267.
8. Bouillet P., Cory S., Zhang L.C., Strasser A., Adams J.M. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell 2001, 1:645-653.
9. Bushati N., Cohen S.M. microRNA functions. Annu. Rev. Cell Dev. Biol. 2007, 23:175-205.
10. Cai B., Chang S.H., Becker E.B., Bonni A., Xia Z. p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J. Biol. Chem. 2006, 281:25215-25222.
11. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
12. Carthew R.W., Sontheimer E.J. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
13. Cartlidge R.A., Thomas G.R., Cagnol S., Jong K.A., Molton S.A., Finch A.J., McMahon M. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell & Melanoma Research 2008, 21:534-544.
14. Chang T.C., Mendell J.T. microRNAs in vertebrate physiology and human disease. Annu. Rev. Genomics Hum. Genet. 2007, 8:215-239.
15. Chang T.C., Zeitels L.R., Hwang H.W., Chivukula R.R., Wentzel E.A., Dews M., Jung J., Gao P., Dang C.V., Beer M.A., et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. USA 2009, 106:3384-3389.
16. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
17. Chin L., Garraway L.A., Fisher D.E. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 2006, 20:2149-2182.
18. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., D'Orazio J., Fung C.Y., Schanbacher C.F., Granter S.R., et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007, 128:853-864.
19. D'Orazio J.A., Nobuhisa T., Cui R., Arya M., Spry M., Wakamatsu K., Igras V., Kunisada T., Granter S.R., Nishimura E.K., et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 2006, 443:340-344.
20. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
21. Davis I.J., Kim J.J., Ozsolak F., Widlund H.R., Rozenblatt-Rosen O., Granter S.R., Du J., Fletcher J.A., Denny C.T., Lessnick S.L., et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 2006, 9:473-484.
22. Delmas V., Martinozzi S., Bourgeois Y., Holzenberger M., Larue L. Cre-mediated recombination in the skin melanocyte lineage. Genesis 2003, 36:73-80.
23. Du T., Zamore P.D. Beginning to understand microRNA function. Cell Res. 2007, 17:661-663.
24. Ewings K.E., Wiggins C.M., Cook S.J. Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 2007, 6:2236-2240.
25. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
26. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., Boldrini R., Donfrancesco A., Federici V., Giacomini P., et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 2008, 3:e2236.
27. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., Beroukhim R., Milner D.A., Granter S.R., Du J., et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
28. Guyonneau L., Murisier F., Rossier A., Moulin A., Beermann F. Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice. Mol. Cell. Biol. 2004, 24:3396-3403.
29. Haase A.D., Jaskiewicz L., Zhang H., Laine S., Sack R., Gatignol A., Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6:961-967.
30. Harfe B.D., McManus M.T., Mansfield J.H., Hornstein E., Tabin C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. USA 2005, 102:10898-10903.
31. Hemesath T.J., Steingrimsson E., McGill G., Hansen M.J., Vaught J., Hodgkinson C.A., Arnheiter H., Copeland N.G., Jenkins N.A., Fisher D.E. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 1994, 8:2770-2780.
32. Heo I., Joo C., Kim Y.K., Ha M., Yoon M.J., Cho J., Yeom K.H., Han J., Kim V.N. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009, 138:696-708.
33. Jaskiewicz L., Filipowicz W. Role of Dicer in posttranscriptional RNA silencing. Curr. Top. Microbiol. Immunol. 2008, 320:77-97.
34. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., Tsujimoto Y. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 1995, 55:354-359.
35. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nature Reviews 2009, 10:126-139.
36. Konig R., Chiang C.Y., Tu B.P., Yan S.F., DeJesus P.D., Romero A., Bergauer T., Orth A., Krueger U., Zhou Y., et al. A probability-based approach for the analysis of large-scale RNAi screens. Nat. Methods 2007, 4:847-849.
37. Koralov S.B., Muljo S.A., Galler G.R., Krek A., Chakraborty T., Kanellopoulou C., Jensen K., Cobb B.S., Merkenschlager M., Rajewsky N., et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132:860-874.
38. Kunisada T., Lu S.Z., Yoshida H., Nishikawa S., Nishikawa S., Mizoguchi M., Hayashi S., Tyrrell L., Williams D.A., Wang X., et al. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J. Exp. Med. 1998, 187:1565-1573.
39. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R., Kim V.N. The role of PACT in the RNA silencing pathway. EMBO J. 2006, 25:522-532.
40. Levy C., Khaled M., Fisher D.E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 2006, 12:406-414.
41. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
42. Ley R., Ewings K.E., Hadfield K., Cook S.J. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ. 2005, 12:1008-1014.
43. Lin J.Y., Fisher D.E. Melanocyte biology and skin pigmentation. Nature 2007, 445:843-850.
44. Lin W.M., Baker A.C., Beroukhim R., Winckler W., Feng W., Marmion J.M., Laine E., Greulich H., Tseng H., Gates C., et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 2008, 68:664-673.
45. Liu Q., Rand T.A., Kalidas S., Du F., Kim H.E., Smith D.P., Wang X. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 2003, 301:1921-1925.
46. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
47. Ma L., Weinberg R.A. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet. 2008, 24:448-456.
48. Mackenzie M.A., Jordan S.A., Budd P.S., Jackson I.J. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 1997, 192:99-107.
49. Maroney P.A., Yu Y., Nilsen T.W. MicroRNAs, mRNAs, and translation. Cold Spring Harb. Symp. Quant. Biol. 2006, 71:531-535.
50. McGill G.G., Horstmann M., Widlund H.R., Du J., Motyckova G., Nishimura E.K., Lin Y.L., Ramaswamy S., Avery W., Ding H.F., et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002, 109:707-718.
51. Medina P.P., Slack F.J. MicroRNAs and cancer: An overview. Cell Cycle 2008, 7:2485-2492.
52. Mendell J.T. miRiad Roles for the miR-17-92 Cluster in Development and Disease. Cell 2008, 133:217-222.
53. Miller A.J., Du J., Rowan S., Hershey C.L., Widlund H.R., Fisher D.E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 2004, 64:509-516.
54. Neilson J.R., Sharp P.A. Small RNA regulators of gene expression. Cell 2008, 134:899-902.
55. Nishimura, E.K., Granter, S.R., and Fisher, D.E. (2005). Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science (New York, NY 307, 720-724.
56. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., Huang D.C. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 1998, 17:384-395.
57. Obernosterer G., Leuschner P.J., Alenius M., Martinez J. Post-transcriptional regulation of microRNA expression. RNA 2006, 12:1161-1167.
58. Osawa M., Egawa G., Mak S.S., Moriyama M., Freter R., Yonetani S., Beermann F., Nishikawa S. Molecular characterization of melanocyte stem cells in their niche. Development 2005, 132:5589-5599.
59. Ozsolak F., Poling L.L., Wang Z., Liu H., Liu X.S., Roeder R.G., Zhang X., Song J.S., Fisher D.E. Chromatin structure analyses identify miRNA promoters. Genes Dev. 2008, 22:3172-3183.
60. Price E.R., Horstmann M.A., Wells A.G., Weilbaecher K.N., Takemoto C.M., Landis M.W., Fisher D.E. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem. 1998, 273:33042-33047.
61. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448:83-86.
62. Schickel R., Boyerinas B., Park S.M., Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27:5959-5974.
63. Schier A.F., Giraldez A.J. MicroRNA function and mechanism: insights from zebra fish. Cold Spring Harb. Symp. Quant. Biol. 2006, 71:195-203.
64. Seely R.J., Munyakazi L., Haury J., Simmerman H., Rushing W.H., Curry T.F. Demonstrating the Consistency of Small Data Sets. Application of the Weisberg t-test for Outliers. BioPharm International 2003, 36-42.
65. Sempere L.F., Sokol N.S., Dubrovsky E.B., Berger E.M., Ambros V. Temporal regulation of microRNA expression in Drosophila melanogaster mediated by hormonal signals and broad-Complex gene activity. Dev. Biol. 2003, 259:9-18.
66. Steingrimsson E., Copeland N.G., Jenkins N.A. Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 2004, 38:365-411.
67. Steingrimsson E., Moore K.J., Lamoreux M.L., Ferre-D'Amare A.R., Burley S.K., Zimring D.C., Skow L.C., Hodgkinson C.A., Arnheiter H., Copeland N.G., et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 1994, 8:256-263.
68. Thomson J.M., Newman M., Parker J.S., Morin-Kensicki E.M., Wright T., Hammond S.M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006, 20:2202-2207.
69. Trabucchi M., Briata P., Garcia-Mayoral M., Haase A.D., Filipowicz W., Ramos A., Gherzi R., Rosenfeld M.G. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
70. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75:229-240.
71. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
72. Viswanathan S.R., Daley G.Q., Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
73. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
74. Wu H., Ye C., Ramirez D., Manjunath N. Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA. PLoS ONE 2009, 4:e7566.
75. Wulczyn F.G., Smirnova L., Rybak A., Brandt C., Kwidzinski E., Ninnemann O., Strehle M., Seiler A., Schumacher S., Nitsch R. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J. 2007, 21:415-426.
76. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., Henderson J.M., Kutok J.L., Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9:405-414.
77. Yamamura K., Kamada S., Ito S., Nakagawa K., Ichihashi M., Tsujimoto Y. Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res. 1996, 56:3546-3550.
78. Yasumoto K., Yokoyama K., Shibata K., Tomita Y., Shibahara S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol. 1994, 14:8058-8070.
79. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews 2008, 9:47-59.
80. Zeng Y., Cullen B.R. Recognition and cleavage of primary microRNA transcripts. Methods in Molecular Biology 2006, 342:49-56.
81. Zhang H., Kolb F.A., Brondani V., Billy E., Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 2002, 21:5875-5885.